August 31, 2017

FDA Approves First CAR-T Cell Therapy

Johann Groder/APA Picturedesk via ZUMA

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily.

Progress:

The Food and Drug Administration on Wednesday approved the first-ever treatment that genetically alters a patient’s own cells to fight cancer, a milestone that is expected to transform treatment in the coming years….The therapy, marketed as Kymriah and made by Novartis, was approved for children and young adults for an aggressive type of leukemia — B-cell acute lymphoblastic leukemia….The treatment was originally developed by researchers at the University of Pennsylvania and licensed to Novartis. It was identified in previous reports as CAR-T cell therapy, CTL019 or tisagenlecleucel.

Hooray! Let’s do multiple myeloma next! This therapy costs half a million bucks or so, but as long as someone else is paying for it I figure I’m worth it.

Take the next step: Help us fight for the truth.

Investigative journalism, like the story you just read, takes time to do. Months of research. Weeks of writing, editing, and fact checking—and putting together the photography, art, video, and audio that tell the stories in a new way, illuminating new perspectives and voices.

We can afford to take that time because we don’t report to an oligarch or corporation with a special agenda. We report to you, and for you. That’s why we unabashedly pursue the truth and relentlessly shine a light into the darkness.

In this month’s Summer Membership Drive, we’ve got to raise $200,000 to support more crucial investigations. This is a pivotal moment in our nation, with democracy on the line, and we can only do this work because readers like you step up. Every donation, of any amount, makes a difference here. We cannot do this work without you.

So, we’re asking: Will you support independent journalism that demands those in power answer for their actions?

Take the next step: Help us fight for the truth.

Investigative journalism, like the story you just read, takes time to do. Months of research. Weeks of writing, editing, and fact checking—and putting together the photography, art, video, and audio that tell the stories in a new way, illuminating new perspectives and voices

We can afford to take that time because we don’t report to an oligarch or corporation with a special agenda. We report to you, and for you. That’s why we unabashedly pursue the truth and relentlessly shine a light into the darkness.

In this month’s Summer Membership Drive, we’ve got to raise $200,000 to support more crucial investigations. This is a pivotal moment in our nation, with democracy on the line, and we can only do this work because readers like you step up. Every donation, of any amount, makes a difference here. We cannot do this work without you.

So, we’re asking: Will you support independent journalism that demands those in power answer for their actions?

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

INDEPENDENT. BECAUSE OF YOU.

Mother Jones has no billionaires calling the shots—just readers like you making fearless reporting possible

Donate